Stifel Financial Corp Opti Nose, Inc. Transaction History

Stifel Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.4 - $10.94 $64,352 - $110,001	-10,055 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$6.1 - $10.3 $549 - $927	-90 Reduced 0.89%	10,055 $104,000
Q4 2018 Feb 13, 2019	BUY	$5.84 - $11.92 $59,246 - $120,928	10,145 New	10,145 $63,000

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $764M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.